Trial Profile
A study investigating pharmacokinetics of rivaroxaban and apixaban for the prevention of thromboembolic complications
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Apixaban
- Indications Thromboembolism
- Focus Pharmacokinetics
- 30 Dec 2015 New trial record